Research Agenda

We are primarily engaged in research pertaining to the development of vaccines and antivirals by:

  1. Understanding the molecular determinants of virulence and antigenicity of pathogenic viruses, namely enterovirus 71 (EV-A71) and dengue virus
  2. Understanding the immune responses of viral pathogens to novel vaccines — synthetic peptide-based and live attenuated  
  3. Designing anti-viral strategies, namely antivirals and antiviral peptides against EV-A71 and dengue
  4. Exploring the future development of therapeutics based on microRNAs in viral and bacterial diseases
  5. Advancing the development of DNA vaccines against antibiotic resistant bacteria

 

 

Share This Page